Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China flag China · Delayed Price · Currency is CNY
20.98
-1.12 (-5.07%)
Apr 29, 2026, 3:04 PM CST

Hybio Pharmaceutical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 2021 - 2017
Cash & Equivalents
100.7294.87344.01106.26138.92
Upgrade
Trading Asset Securities
1.231.11-160.57477.68
Upgrade
Cash & Short-Term Investments
101.9595.97344.01266.83616.6
Upgrade
Cash Growth
6.23%-72.10%28.92%-56.73%36.52%
Upgrade
Accounts Receivable
131.4399.87145.42318.07282.64
Upgrade
Other Receivables
6.5511.1522.4411.8854.39
Upgrade
Receivables
137.98111.02167.87329.95337.03
Upgrade
Inventory
261.38238.63152.59189.96157.14
Upgrade
Prepaid Expenses
-10.292.560.19-
Upgrade
Other Current Assets
22.247.1416.6125.3944.31
Upgrade
Total Current Assets
523.56463.05683.64812.321,155
Upgrade
Property, Plant & Equipment
1,7451,6741,7341,9421,993
Upgrade
Long-Term Investments
5.9589.11105.85131.11139.74
Upgrade
Goodwill
----0.19
Upgrade
Other Intangible Assets
262.85293.41222.5265.05263.56
Upgrade
Long-Term Deferred Tax Assets
41.8843.7639.5538.0134.07
Upgrade
Long-Term Deferred Charges
200.7175.99217.81250.41228.02
Upgrade
Other Long-Term Assets
373.9268.53273.73172.593.2
Upgrade
Total Assets
3,1543,0083,2773,6113,906
Upgrade
Accounts Payable
261.97218.26108.5129.0590.73
Upgrade
Accrued Expenses
28.6478.5100.9249.1672.78
Upgrade
Short-Term Debt
1,033638.99634.21320.92338.23
Upgrade
Current Portion of Long-Term Debt
249.98293.53453.18456.1163.05
Upgrade
Current Portion of Leases
-0.820.212.8811.06
Upgrade
Current Income Taxes Payable
16.026.722.84-0.32
Upgrade
Current Unearned Revenue
102.96130.5555.3362.6948.79
Upgrade
Other Current Liabilities
88.8357.1768.26127.14118.86
Upgrade
Total Current Liabilities
1,7821,4251,4231,148743.82
Upgrade
Long-Term Debt
623.4864.58942.051,0261,377
Upgrade
Long-Term Unearned Revenue
97.69106.91101.19118.62124.73
Upgrade
Long-Term Deferred Tax Liabilities
15.418.845.014.20.81
Upgrade
Other Long-Term Liabilities
5.826.2922.2917.0612.3
Upgrade
Total Liabilities
2,5242,4112,4942,3142,258
Upgrade
Common Stock
883.24883.24883.24916.93916.93
Upgrade
Additional Paid-In Capital
1,4481,4481,4631,7481,700
Upgrade
Retained Earnings
-1,757-1,794-1,627-1,113-740
Upgrade
Treasury Stock
----318.66-318.66
Upgrade
Comprehensive Income & Other
39.9741.2239.2737.526.51
Upgrade
Total Common Equity
613.95578.63758.81,2711,585
Upgrade
Minority Interest
15.9818.4224.4126.363.31
Upgrade
Shareholders' Equity
629.93597.05783.211,2971,648
Upgrade
Total Liabilities & Equity
3,1543,0083,2773,6113,906
Upgrade
Total Debt
1,9071,7982,0301,8061,789
Upgrade
Net Cash (Debt)
-1,805-1,702-1,686-1,540-1,173
Upgrade
Net Cash Per Share
-1.97-1.96-1.90-1.74-1.14
Upgrade
Filing Date Shares Outstanding
981.31883.24883.24883.24883.24
Upgrade
Total Common Shares Outstanding
981.31883.24883.24883.24883.24
Upgrade
Working Capital
-1,258-961.51-739.8-335.63411.26
Upgrade
Book Value Per Share
0.630.660.861.441.79
Upgrade
Tangible Book Value
351.1285.21536.311,0061,321
Upgrade
Tangible Book Value Per Share
0.360.320.611.141.50
Upgrade
Buildings
-1,5771,5601,5371,058
Upgrade
Machinery
-896.3832.92774.95769.85
Upgrade
Construction In Progress
-37.1167.32153.99699.74
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.